Clinical Trial Update: A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for TH-302 in locally advanced unresectable or metastatic soft tissue sarcoma; trial terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• TH-302 (evofosfamide)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2018-12-14